Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

• Status: Completed
• Trial end date: 2015-07-15

Summary

The purpose of this study is to determine if fluticasone furoate/vilanterol improves survival in patients with chronic obstructive pulmonary disease with a history of or increased risk of heart disease.

• Phase: Phase 3

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Xhance